Healthcare -
Biotechnology - NASDAQ - US
$ 1.77
-3.28 %
$ 105 M
Market Cap
-0.49
P/E
Price Target
Average
965.38%
Revenue Forecast
Estimate
202.38%
EBIT
Estimate
26.92%
Net Income
Estimate
30.11%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
IGM Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for IGMS of $18.9 , with forecasts ranging from
a
low of
$12 to a high of $25 .
IGMS Lowest Price Target
Wall Street Target
12 USD
577.97%
IGMS Average Price Target
Wall Street Target
18.9 USD
965.38%
IGMS Highest Price Target
Wall Street Target
25 USD
1312.43%
REVENUE FORECAST
Revenue Forecast Chart IGMS
EBIT FORECAST
EBIT Forecast Chart IGMS
NET INCOME FORECAST
Net Income Chart IGMS